InHeAb-01

N/A

Report date: 2026/03/19 17:18:45

Base Information

Drug NameInHeAb-01

Drug Alias NameInHeAb-01bsAB

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Anti-CD28

TargetsT cell surface glycoprotein CD3T-cell-specific surface glycoprotein CD28

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Hospital Tuebingen

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital Tuebingen

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A